Histone deacetylase inhibitors: From bench to clinic

被引：350

作者：

Paris, Marielle ^{[1
]}

Porcelloni, Marina ^{[1
]}

Binaschi, Monica ^{[1
]}

Fattori, Daniela ^{[1
]}

机构：

[1] Menarini Ric, I-0004 Rome, Italy

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 06期

关键词：

D O I：

10.1021/jm7011408

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：1505 / 1529

页数：25

共 177 条

[61] Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA [J].

Glaser, KB ;

Li, JL ;

Staver, MJ ;

Wei, RQ ;

Albert, DH ;

Davidsen, SK .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (02) :529-536

[62] HDAC inhibitors: Clinical update and mechanism-based potential [J].

Glaser, Keith B. .

BIOCHEMICAL PHARMACOLOGY, 2007, 74 (05) :659-671

[63] Antiproliferative and phenotype-transforming antitumor agents derived from cysteine [J].

Glenn, MP ;

Kahnberg, P ;

Boyle, GM ;

Hansford, KA ;

Hans, D ;

Martyn, AC ;

Parsons, PG ;

Fairlie, DP .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (12) :2984-2994

[64]

GROSSMANN A, 2004, Patent No. 200405999

[65]

GROSSMANN A, 2004, Patent No. 200405499

[66] Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases [J].

Gu, WX ;

Nusinzon, I ;

Smith, RD ;

Horvath, CM ;

Silverman, RB .

BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (10) :3320-3329

[67]

Guidi A., 2006, [No title captured], Patent No. [WO 2006097449, 2006097449]

[68] Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity [J].

Harms, Kelly Lynn ;

Chen, Xinbin .

CANCER RESEARCH, 2007, 67 (07) :3145-3152

[69]

HOFFMANN LA ROCHE LT, 2004, Patent No. 2004087693

[70]

HOFFMANN LA ROCHE LT, 2004, Patent No. 2004069803

← 2 3 4 5 6 7 8 9 10 11 →